Clinical Trial Update: Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating different doses and durations of low molecular weight heparin (parnaparin) for superficial vein thrombosis (thrombophlebitis) has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombophlebitis

Drugs mentioned

• Parnaparin (parnaparin)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Thrombophlebitis | Phase 3 | Status: COMPLETED